VTAK
Catheter Precision Inc.
AMEX: VTAK · HEALTHCARE · MEDICAL DEVICES
$0.18
+6.06% today
Updated 2026-09-11
Market cap
$758350.00
P/E ratio
—
P/S ratio
0.40x
EPS (TTM)
$-4.07
Dividend yield
—
52W range
$0 – $3
Volume
9.8M
WallStSmart proprietary scores
43
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-31.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$2.00
+1042.86%
12-Month target
$2.02
+1054.29%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Revenue growth 380.70% QoQ
+ Debt/equity 0.19x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -31.10 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-2.89M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $14000.00 | $442000.00 | $420000.00 | $819000.00 | $1.92M |
| Net income | $-26.86M | $-70.57M | $-16.64M | $-17.18M | $-3.92M |
| EPS | — | — | — | — | $-4.07 |
| Free cash flow | $-22.59M | $-20.70M | $-9.34M | $-8.31M | $-2.89M |
| Profit margin | -191,892.86% | -15,966.52% | -3,962.62% | -2,098.05% | — |
Peer comparison
Smart narrative
Catheter Precision Inc. trades at $0.18. Our Smart Value Score of 43/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -31.10, it sits in the distress. TTM revenue stands at $1.92M.
Frequently asked questions
What is Catheter Precision Inc.'s stock price?
Catheter Precision Inc. (VTAK) trades at $0.18, on a P/S of 0.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Catheter Precision Inc. overvalued?
Catheter Precision Inc. carries a Smart Value Score of 43/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Catheter Precision Inc. (VTAK)?
The 12-month analyst consensus target is $2.00, about 1042.9% above the current $0.18. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Catheter Precision Inc.'s revenue?
Catheter Precision Inc.'s trailing twelve-month revenue is $1.92M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Catheter Precision Inc.'s Altman Z-Score is -31.10, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeAMEX
CurrencyUSD
Quick metrics
P/S ratio0.40x
ROE-169.08%
Beta0.48
50D MA$0.58
200D MA$1.31
Shares out0.00B
Float0.00B
Short ratio—
Avg volume9.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—